JP3696271B2 - Whitening cosmetics - Google Patents
Whitening cosmetics Download PDFInfo
- Publication number
- JP3696271B2 JP3696271B2 JP22802694A JP22802694A JP3696271B2 JP 3696271 B2 JP3696271 B2 JP 3696271B2 JP 22802694 A JP22802694 A JP 22802694A JP 22802694 A JP22802694 A JP 22802694A JP 3696271 B2 JP3696271 B2 JP 3696271B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- whitening
- ascorbic acid
- acid
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Cosmetics (AREA)
Description
【０００１】
【産業上の利用分野】
本発明は皮膚美白効果に優れ、日焼け等によるしみ及びそばかすを予防及び治療することのできる美白化粧料に関する。
【０００２】
【従来の技術及び発明が解決しようとする課題】
皮膚のしみ及びそばかすは、一般には日光からの紫外線暴露による刺激やホルモンの異常、又は遺伝的要素等が原因となって色素細胞（メラノサイト）が活性化された結果、色素細胞で合成されたメラニン色素が皮膚内に異常沈着して発生するものと考えられている。
【０００３】
従来、このようなしみ及びそばかすに対する予防又は治療の方法として、Ｌ−アスコルビン酸及びその誘導体、ハイドロキノン誘導体、コウジ酸及びその誘導体、胎盤抽出物等のメラニン抑制剤等が用いられているが、これらの物質は単独で使用した場合、メラニン生成抑制効果が弱く、化粧品等に配合した場合、充分な美白効果を発現できないものが多かった。
【０００４】
従って、皮膚の美白効果に優れ、しみ及びそばかすを有効に予防及び治療することのできる美白化粧料が望まれていた。
【０００５】
【課題を解決するための手段】
このような実情に鑑み、本発明者らは鋭意検討を重ねた結果、カミツレ抽出物と特定の植物抽出物と特定の美白剤とを組み合わせて用いれば相乗的に美白効果が増強され、しみ及びそばかすを有効に予防及び治療することのできる美白化粧料が得られることを見出し、本発明を完成した。
【０００６】
すなわち、本発明は、次の成分（Ａ）、（Ｂ）及び（Ｃ）：
（Ａ）カミツレ抽出物を固形分として０．００００１〜５重量％、
（Ｂ）茶、葛根、丁子、橙皮、高麗人参、山査子、生姜、アルテア、オランダガラシ及びロートの抽出物から選ばれる一種又は二種以上の植物抽出物を固形分として０．００００１〜５重量％、
（Ｃ）Ｌ−アスコルビン酸及びその誘導体並びに胎盤抽出物から選ばれる一種又は二種以上の美白剤を０．０１〜３０重量％、
を含有する美白化粧料を提供するものである。
【０００７】
本発明で用いられる成分（Ａ）のカミツレ抽出物は、カミツレ〔Ｍａｔｒｉｃａｒｉａ ｃｈａｍｏｍｉｌｌａ Ｌ．（Ｃｏｍｐｏｓｉｔａｅ）〕の花を水もしくはメタノール、エタノール、プロパノール、プロピレングリコール、１，３−ブチレングリコール等の親水性有機溶媒又はこれらの混合溶媒で抽出することにより抽出液として得ることができ、また当該抽出液を乾燥して乾燥粉末の形態で得ることができる。また、ヒマシ油、パーシック油、流動パラフィン、大豆油、ミリスチン酸イソプロピル、低級脂肪酸トリグリセリド、中級脂肪酸トリグリセリド、ヒマワリ油、ジカプリン酸ネオペンチルグリコール、スクワラン等の親油性有機溶媒又はこれらの混合溶媒で抽出することにより得ることができる。本発明においては、このようにして得られるカミツレ抽出物の一種又は二種以上を組み合わせて用いることができる。
【０００８】
かかるカミツレ抽出物には、一般にアズレン、カマズレン、ウンベリフェロン、７−メトキシクマリン、マトリシン、マトリカリン、タラキサステロール、ルペオール、アピイン、クロマン等が含まれている。
ここで、カミツレの好ましい抽出方法としては、例えば次の方法が挙げられる。
【０００９】
カミツレの花を乾燥し、細切する。それにスクワランを加え、時々攪拌しながら室温から５０℃で浸漬した後、圧搾分離して抽出液を得る。この抽出液を濾過してカミツレ抽出エキスとする。
【００１０】
成分（Ａ）の配合量は特に制限されるものではないが、美白効果及び保存安定性の点から、化粧料全量中に固形分として０．００００１〜５重量％配合するのが好ましく、特に０．０００５〜３重量％、更に０．００１〜２重量％配合すると、十分な美白効果が得られ、また製品の保存安定性にも優れるので好ましい。
【００１２】
本発明で用いられる成分（Ｂ）の植物抽出物は前記のカミツレ抽出物と同様の操作によって得ることができる。
【００１３】
成分（Ｂ）の配合量は特に限定されるものではないが、美白効果及び保存安定性の点から、化粧料全量中に固形分で０．００００１〜５重量％配合するのが好ましく、特に０．０００５〜３重量％、更に０．００１〜３重量％配合すると、十分な美白効果が得られ保存安定性も良好なので好ましい。
【００１４】
本発明で用いられる成分（Ｃ）の美白剤のうちアスコルビン酸及びその誘導体としては、特に限定されるものではなく、例えばＬ−アスコルビン酸リン酸エステルの１価金属塩であるＬ−アスコルビン酸リン酸エステルナトリウム塩、Ｌ−アスコルビン酸リン酸エステルカリウム塩、２価金属塩であるＬ−アスコルビン酸リン酸エステルマグネシウム塩、Ｌ−アスコルビン酸リン酸エステルカルシウム塩、３価金属塩であるＬ−アスコルビン酸リン酸エステルアルミニウム塩、またＬ−アスコルビン酸硫酸エステルの１価金属塩であるＬ−アスコルビン酸硫酸エステルナトリウム塩、Ｌ−アスコルビン酸硫酸エステルカリウム塩、２価金属塩であるＬ−アスコルビン酸硫酸エステルカリウムマグネシウム塩、Ｌ−アスコルビン酸硫酸エステルカルシウム塩、３価金属塩であるＬ−アスコルビン酸硫酸エステルアルミニウム塩、Ｌ−アスコルビン酸の１価金属塩であるＬ−アスコルビン酸ナトリウム塩、Ｌ−アスコルビン酸カリウム塩、２価金属塩であるＬ−アスコルビン酸マグネシウム塩、Ｌ−アスコルビン酸カルシウム塩、３価金属塩であるＬ−アスコルビン酸アルミニウム塩等を好ましいものとして挙げることができる。
【００１７】
胎盤抽出物としては水溶性プラセンタエキスとして一般に市販され化粧品原料として使用されているものを用いることができ、例えば牛や豚又はヒト等の哺乳動物の胎盤を洗浄、除血、破砕、凍結等の工程を経て、水溶性成分を抽出した後、更に不純物を除去して得られるものを挙げることができる。
【００１９】
成分（Ｃ）の美白剤は、一種を単独で又は二種以上を組み合わせて用いることができ、その配合量は特に制限されるものではないが、美白効果、保存安定性及び使用感の点から、化粧料全量中に０．０１〜３０重量％配合するのが好ましく、特に０．０１〜１０重量％、更に０．０１〜５重量％配合すると、十分な美白効果が得られ、かつ安定性も良好なので好ましい。
【００２０】
本発明の美白化粧料には、更に有機酸又は有機酸塩から選ばれる一種又は二種以上を配合することが好ましい。有機酸とは、一分子中に一個以上のカルボキシル基を含有する化合物をいい、例えば乳酸、クエン酸、酒石酸、グリセリン酸、リンゴ酸、コハク酸、グリコール酸、フマール酸、アミノ酸、カルボン酸、オキシカルボン酸等が挙げられる。また、有機酸塩とはこれらの有機酸の金属塩であり、金属塩としてはナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩等が挙げられる。
【００２１】
更に、本発明の美白化粧料には本発明の効果を損なわない範囲において、上記成分の他に通常化粧品や医薬部外品、医薬品等に用いられる各種任意成分を必要に応じて適宜配合することができる。このような任意成分としては、例えば精製水、エタノール、油性物質、保湿剤、増粘剤、防腐剤、乳化剤、薬効成分、粉体、紫外線吸収剤、色素、香料、乳化安定剤等を挙げることができる。
【００２２】
油性成分としては、例えば流動パラフィン、ワセリン、パラフィンワックス、スクワラン、ミツロウ、カルナバロウ、オリーブ油、ラノリン、高級アルコール、脂肪酸、高級アルコールと脂肪酸の合成エステル油、シリコーン油等が挙げられる。保湿剤としては、例えばソルビトール、キシリトール、グリセリン、マルチトール、プロピレングリコール、１，３−ブチレングリコール、１，４−ブチレングリコール、ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム、ポリオキシプロピレン脂肪酸エステル、ポリエチレングリコール等が挙げられる。増粘剤としては、例えばカルボキシビニルポリマー、カルボキシメチルセルロース、ポリビニルアルコール、カラギーナン、ゼラチン等の水溶性高分子、塩化ナトリウム、塩化カリウム等の電解質が挙げられる。防腐剤としては、例えば尿素、メチルパラベン、エチルパラベン、プロピルパラベン、ブチルパラベン、安息香酸ナトリウム等が挙げられる。乳化剤としては、例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビトール脂肪酸エステル等の非イオン性界面活性剤が挙げられる。粉体としては、例えばタルク、セリサイト、マイカ、カオリン、シリカ、ベントナイト、バーミキュライト、亜鉛華、雲母、雲母チタン、酸化チタン、酸化マグネシウム、酸化ジルコニウム、硫酸バリウム、ベンガラ、酸化鉄、群青等が挙げられる。
【００２３】
本発明の美白化粧料は常法に従って製造することができる。また、本発明の対象となる美白化粧料は、一般の皮膚化粧料に限定されるものではなく、医薬部外品、外用医薬品等を包含するものであり、その剤型もその目的に応じて任意に選択することができ、クリーム状、軟膏状、乳液状、ローション状、溶液状、ゲル状、パック状、パウダー状、スティック状等とすることができる。
【００２４】
【発明の効果】
本発明の美白化粧料は、カミツレ抽出物、特定の植物抽出物及び特定の美白剤とを併用することにより、相乗的なメラニン生成抑制効果が得られるため、非常に優れた皮膚の美白効果を有し、日焼け等によるしみやそばかすの予防及び治療に有効なものである。
【００２５】
【実施例】
次に、実施例を挙げて本発明を説明するが、本発明はこれらの実施例に何ら限定されるものではない。なお、実施例における美白効果の評価は以下に示すＵＶ−Ｂ誘導色素斑に対する美白効果試験により行った。以下の実施例中、表２中の実施例２、５、６、７及び９、表４中の実施例２、５、６、７及び９、並びに実施例１３は参考例である。
【００２６】
（ＵＶ−Ｂ誘導色素斑に対する美白効果試験）
被験者２０名の上腕内側部にＵＶ−Ｂ領域の紫外線を最小紅斑量の２倍量を１日１回２日間にわたり照射し、誘導した色素斑に、１日２回、１ケ月間被験部位に試料を連続塗布することによる美白効果を調べた。
【００２７】
評価は、色差計（村上色彩製、ＣＭＳ−１２００）を用いて測定を行い、得られたマンセル値よりＬ*値を算出し、その回復をあらわすΔΔＬ*値を用いた。なお、ΔΔＬ*値は以下のように定義した。
【００２８】
試料塗布開始直前の試料塗布被験部位及び試料未塗布被験部位のＬ*値をそれぞれＬ0、Ｌ0 '、連続塗布１ケ月後の各々の部位のＬ*値をそれぞれＬ1、Ｌ1 'とし、ΔΔＬ*は以下の式で表わした。
【００２９】
【数１】
ΔΔＬ*＝（Ｌ1−Ｌ0）−（Ｌ1 '−Ｌ0 '）
【００３０】
また、評価は被験者２０名の表１に示す評価点の平均値で示した。
【００３１】
【表１】
実施例１〜１０、比較例１〜７
カミツレ抽出物とカミツレ以外の各種植物抽出物及び美白剤を表２の組成で配合したクリームを表３の配合組成に従って調製し、その連続塗布による美白効果を前記に示す方法で評価した。結果を表３に示す。
【００３３】
【表２】
【表３】
（製法）
油層成分を８０℃で加熱溶解し攪拌しながら６０℃に加熱した水層を加え乳化し、攪拌しながら室温まで冷却してクリームを調製した。
【００３６】
【表４】
表４の結果より、本発明の美白クリームは、美白効果が相乗的に向上して、優れた美白効果が得られることが確認された。
【００３８】
実施例１１ 乳液
【００３９】
【表５】
（製法）
油層成分を８０℃で加熱溶解し攪拌しながら、６０℃に加熱した水層を加え乳化し、乳化終了後、攪拌しながら、室温まで冷却して乳液を調製した。
【００４１】
実施例１２ エッセンス
【００４２】
【表６】
（製法）
油層成分を８０℃で加熱溶解し攪拌しながら、８０℃に加熱した水層を加え乳化し、乳化終了後、攪拌しながら、室温まで冷却してエッセンスを調製した。
【００４４】
実施例１３ ローション
【００４５】
【表７】
（製法）
配合成分を８０℃で加熱溶解しながら系が均一になるまで攪拌し、更に攪拌しながら、室温まで冷却してローションを調製した。
【００４７】
実施例１４ パウダー
【００４８】
【表８】
（製法）
配合成分を均一に攪拌し、混合してパウダーを調製した。
【００５０】
実施例１５ パック
【００５１】
【表９】
（製法）
配合成分を均一に攪拌し、混合した後、室温まで冷却してパックを調製した。[0001]
[Industrial application fields]
The present invention relates to a whitening cosmetic that has an excellent skin whitening effect and can prevent and treat spots and freckles caused by sunburn.
[0002]
[Prior art and problems to be solved by the invention]
Skin spots and freckles are generally melanin synthesized in pigment cells as a result of activation of pigment cells (melanocytes) due to stimulation by ultraviolet exposure from sunlight, hormonal abnormalities, or genetic factors. It is thought that pigment is abnormally deposited in the skin.
[0003]
Conventionally, L-ascorbic acid and its derivatives, hydroquinone derivatives, kojic acid and its derivatives, melanin inhibitors such as placenta extract, etc. have been used as a method for preventing or treating such stains and freckles. When used alone, the effect of inhibiting the formation of melanin is weak, and when it is blended in cosmetics, there are many substances that cannot exhibit a sufficient whitening effect.
[0004]
Therefore, there has been a demand for a whitening cosmetic that has an excellent skin whitening effect and can effectively prevent and treat stains and freckles.
[0005]
[Means for Solving the Problems]
In view of such circumstances, the present inventors have conducted extensive studies, and as a result, the whitening effect is synergistically enhanced by using a combination of a chamomile extract, a specific plant extract and a specific whitening agent. The inventors have found that a whitening cosmetic capable of effectively preventing and treating freckles is obtained, and have completed the present invention.
[0006]
That is, the present invention includes the following components (A), (B) and (C):
(A) 0.00001-5 wt% of chamomile extract as solid content,
(B) 0.00001-5 wt. As a solid content of one or more plant extracts selected from tea, kudzu, clove, orange peel, ginseng, ginseng, ginger, altea, Dutch pepper and funnel extract %,
(C) L-ascorbic acid and one or two or more of the whitening agent 0.01 to 30 wt% selected from the placenta extract thereof derived thereof parallel Beauty,
The whitening cosmetics containing this are provided.
[0007]
The chamomile extract of component (A) used in the present invention is chamomile [Matricaria chamomill L. (Compositae)] can be obtained as an extract by extracting with water or a hydrophilic organic solvent such as methanol, ethanol, propanol, propylene glycol, 1,3-butylene glycol or a mixed solvent thereof. The extract can be dried and obtained in the form of a dry powder. Extract with lipophilic organic solvents such as castor oil, persic oil, liquid paraffin, soybean oil, isopropyl myristate, lower fatty acid triglyceride, intermediate fatty acid triglyceride, sunflower oil, neopentyl glycol dicaprate, squalane, or a mixed solvent thereof. Can be obtained. In the present invention, one or two or more chamomile extracts thus obtained can be used in combination.
[0008]
Such chamomile extract generally contains azulene, camazulene, umbelliferone, 7-methoxycoumarin, matricin, matricalin, taraxasterol, lupeol, apiin, chroman and the like.
Here, as a preferable method for extracting chamomile, for example, the following method may be mentioned.
[0009]
Dry and shred the chamomile flowers. Squalane is added thereto, and the mixture is immersed at room temperature to 50 ° C. with occasional stirring, followed by pressing and separation to obtain an extract. This extract is filtered to obtain a chamomile extract.
[0010]
The blending amount of the component (A) is not particularly limited, but from the viewpoint of whitening effect and storage stability, it is preferable to blend 0.00001 to 5% by weight as a solid content in the total amount of the cosmetic, particularly 0. It is preferable to add 0.005 to 3% by weight and further 0.001 to 2% by weight because a sufficient whitening effect can be obtained and the storage stability of the product is excellent.
[0012]
The plant extract of the component (B) used by this invention can be obtained by operation similar to the said chamomile extract.
[0013]
Although the compounding quantity of a component (B) is not specifically limited, From the point of a whitening effect and a storage stability, it is preferable to mix | blend 0.00001-5 weight% with solid content in the cosmetics whole quantity, and is especially 0. It is preferable to add 0.005 to 3% by weight, and further 0.001 to 3% by weight, since a sufficient whitening effect is obtained and the storage stability is good.
[0014]
Of the whitening agent of component (C) used in the present invention, ascorbic acid and derivatives thereof are not particularly limited. For example, L-ascorbic acid phosphorus which is a monovalent metal salt of L-ascorbic acid phosphate L-ascorbic acid sodium salt, L-ascorbic acid phosphate potassium salt, divalent metal salt L-ascorbic acid phosphate magnesium salt, L-ascorbic acid phosphate calcium salt, trivalent metal salt Acid phosphate aluminum salt, L-ascorbic acid sulfate sodium salt, L-ascorbic acid sulfate potassium salt, L-ascorbic acid sulfate potassium salt, divalent metal salt L-ascorbic acid sulfuric acid Ester potassium magnesium salt, L-ascorbic acid sulfate L-ascorbic acid sulfate aluminum salt which is a trivalent metal salt, L-ascorbic acid sodium salt, L-ascorbic acid sodium salt which is a monovalent metal salt of L-ascorbic acid, L-ascorbic acid potassium salt and L which is a divalent metal salt -Ascorbic acid magnesium salt, L-ascorbic acid calcium salt, L-ascorbic acid aluminum salt which is a trivalent metal salt etc. can be mentioned as a preferable thing.
[0017]
As the placenta extract, one that is generally marketed as a water-soluble placenta extract and is used as a raw material for cosmetics can be used, for example, washing, blood removal, crushing, freezing, etc. of a placenta of a mammal such as a cow, pig or human. Examples thereof include those obtained by extracting the water-soluble component through the process and further removing impurities.
[0019]
The whitening agent of component (C) can be used singly or in combination of two or more, and the blending amount is not particularly limited, but from the point of whitening effect, storage stability and feeling of use In addition, it is preferable to mix 0.01 to 30% by weight in the total amount of the cosmetic, and particularly when 0.01 to 10% by weight, and further 0.01 to 5% by weight, a sufficient whitening effect can be obtained and the stability can be obtained. Is also preferable.
[0020]
The whitening cosmetic composition of the present invention preferably further contains one or more selected from organic acids or organic acid salts. Organic acid refers to a compound containing one or more carboxyl groups in one molecule, such as lactic acid, citric acid, tartaric acid, glyceric acid, malic acid, succinic acid, glycolic acid, fumaric acid, amino acid, carboxylic acid, oxy A carboxylic acid etc. are mentioned. The organic acid salt is a metal salt of these organic acids, and examples of the metal salt include sodium salt, potassium salt, calcium salt, magnesium salt and the like.
[0021]
Furthermore, in the whitening cosmetics of the present invention, various optional components that are usually used in cosmetics, quasi-drugs, pharmaceuticals and the like are appropriately blended as necessary in addition to the above-mentioned components within a range not impairing the effects of the present invention. Can do. Examples of such optional components include purified water, ethanol, oily substances, humectants, thickeners, preservatives, emulsifiers, medicinal ingredients, powders, ultraviolet absorbers, dyes, fragrances, and emulsion stabilizers. Can do.
[0022]
Examples of the oil component include liquid paraffin, petrolatum, paraffin wax, squalane, beeswax, carnauba wax, olive oil, lanolin, higher alcohol, fatty acid, higher alcohol and fatty acid synthetic ester oil, and silicone oil. Examples of the humectant include sorbitol, xylitol, glycerin, maltitol, propylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, sodium pyrrolidonecarboxylate, lactic acid, sodium lactate, polyoxypropylene fatty acid ester, polyethylene glycol Etc. Examples of the thickener include water-soluble polymers such as carboxyvinyl polymer, carboxymethylcellulose, polyvinyl alcohol, carrageenan, and gelatin, and electrolytes such as sodium chloride and potassium chloride. Examples of the preservative include urea, methyl paraben, ethyl paraben, propyl paraben, butyl paraben, sodium benzoate and the like. Examples of the emulsifier include polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene Nonionic surfactants such as sorbitol fatty acid esters are listed. Examples of the powder include talc, sericite, mica, kaolin, silica, bentonite, vermiculite, zinc white, mica, mica titanium, titanium oxide, magnesium oxide, zirconium oxide, barium sulfate, bengara, iron oxide, ultramarine and the like. It is done.
[0023]
The whitening cosmetic composition of the present invention can be produced according to a conventional method. Moreover, the whitening cosmetics that are the subject of the present invention are not limited to general skin cosmetics, but include quasi-drugs, external medicines, etc. It can be selected arbitrarily, and can be in the form of cream, ointment, emulsion, lotion, solution, gel, pack, powder, stick or the like.
[0024]
【The invention's effect】
Since the whitening cosmetic composition of the present invention can be used in combination with a chamomile extract, a specific plant extract and a specific whitening agent, a synergistic melanin production inhibitory effect can be obtained. It is effective for the prevention and treatment of spots and freckles caused by sunburn.
[0025]
【Example】
EXAMPLES Next, although an Example is given and this invention is demonstrated, this invention is not limited to these Examples at all. In addition, evaluation of the whitening effect in an Example was performed by the whitening effect test with respect to the UV-B induction pigment spot shown below. Of the following examples, Examples 2, 5, 6, 7, and 9 in Table 2, Examples 2, 5, 6, 7, and 9, and Example 13 in Table 4 are reference examples.
[0026]
(Whitening effect test for UV-B-induced pigment spots)
Twenty subjects were irradiated with UV rays in the UV-B region twice the minimum amount of erythema once a day for 2 days. The induced pigment spots were applied twice a day to the test site for 1 month. The whitening effect by continuously applying the sample was examined.
[0027]
Evaluation was performed using a color difference meter (manufactured by Murakami Color Co., Ltd., CMS-1200), an L * value was calculated from the obtained Munsell value, and a ΔΔL * value representing the recovery was used. The ΔΔL * value was defined as follows.
[0028]
The L * values of the sample application test site and the sample non-application test site immediately before the start of sample application are L 0 and L 0 ′ , respectively, and the L * values of the respective sites one month after continuous application are L 1 and L 1 ′ , respectively. , ΔΔL * is expressed by the following equation.
[0029]
[Expression 1]
ΔΔL * = (L 1 −L 0 ) − (L 1 ′ −L 0 ′ )
[0030]
Moreover, evaluation was shown with the average value of the evaluation score shown in Table 1 of 20 test subjects.
[0031]
[Table 1]
Examples 1-10, Comparative Examples 1-7
The cream which mix | blended the chamomile extract and various plant extracts other than chamomile and the whitening agent with the composition of Table 2 was prepared according to the composition of Table 3, and the whitening effect by the continuous application was evaluated by the method described above. The results are shown in Table 3.
[0033]
[Table 2]
[Table 3]
(Manufacturing method)
The oil layer component was heated and dissolved at 80 ° C., and an aqueous layer heated to 60 ° C. was added and emulsified with stirring, and cooled to room temperature with stirring to prepare a cream.
[0036]
[Table 4]
From the results of Table 4, it was confirmed that the whitening cream of the present invention synergistically improves the whitening effect and provides an excellent whitening effect.
[0038]
Example 11 Latex
[Table 5]
(Manufacturing method)
An oil layer component was heated and dissolved at 80 ° C. and stirred, and an aqueous layer heated to 60 ° C. was added to emulsify. After the emulsification, the emulsion was cooled to room temperature while stirring to prepare an emulsion.
[0041]
Example 12 Essence [0042]
[Table 6]
(Manufacturing method)
An oil layer component was heated and dissolved at 80 ° C. and stirred, and an aqueous layer heated to 80 ° C. was added to emulsify. After the emulsification, the mixture was cooled to room temperature with stirring to prepare an essence.
[0044]
Example 13 Lotion [0045]
[Table 7]
(Manufacturing method)
The ingredients were stirred while dissolving at 80 ° C. until the system became homogeneous, and further cooled to room temperature while stirring to prepare a lotion.
[0047]
Example 14 Powder [0048]
[Table 8]
(Manufacturing method)
The ingredients were uniformly stirred and mixed to prepare a powder.
[0050]
Example 15 Pack [0051]
[Table 9]
(Manufacturing method)
The ingredients were uniformly stirred and mixed, and then cooled to room temperature to prepare a pack.
Claims (1)
（Ａ）カミツレ抽出物を固形分として０．００００１〜５重量％、
（Ｂ）茶、葛根、丁子、橙皮、高麗人参、山査子、生姜、アルテア、オランダガラシ及びロートの抽出物から選ばれる一種又は二種以上の植物抽出物を固形分として０．００００１〜５重量％、
（Ｃ）Ｌ−アスコルビン酸及びその誘導体並びに胎盤抽出物から選ばれる一種又は二種以上の美白剤を０．０１〜３０重量％、
を含有する美白化粧料。The following components (A), (B) and (C):
(A) 0.00001-5 wt% of chamomile extract as solid content,
(B) 0.00001-5 wt. As a solid content of one or more plant extracts selected from tea, kudzu, clove, orange peel, ginseng, ginseng, ginger, altea, Dutch pepper and funnel extract %,
(C) L-ascorbic acid and one or two or more of the whitening agent 0.01 to 30 wt% selected from the placenta extract thereof derived thereof parallel Beauty,
Whitening cosmetics containing
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22802694A JP3696271B2 (en) | 1994-09-22 | 1994-09-22 | Whitening cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22802694A JP3696271B2 (en) | 1994-09-22 | 1994-09-22 | Whitening cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0892056A JPH0892056A (en) | 1996-04-09 |
| JP3696271B2 true JP3696271B2 (en) | 2005-09-14 |
Family
ID=16870040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP22802694A Expired - Fee Related JP3696271B2 (en) | 1994-09-22 | 1994-09-22 | Whitening cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3696271B2 (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3911642B2 (en) * | 1995-06-06 | 2007-05-09 | 株式会社加美乃素本舗 | Topical skin preparation |
| KR19980068393A (en) * | 1997-02-19 | 1998-10-15 | 성재갑 | Whitening Soap Composition |
| JP3592918B2 (en) * | 1997-05-14 | 2004-11-24 | 花王株式会社 | Cosmetics |
| JP4677063B2 (en) * | 1997-07-18 | 2011-04-27 | 帝國製薬株式会社 | Dutch mustard extract combination external preparation |
| KR100516447B1 (en) * | 1997-11-20 | 2005-12-06 | 주식회사 엘지생활건강 | Cosmetic composition containing root extract with excellent astringent effect |
| WO1999047006A1 (en) * | 1998-03-19 | 1999-09-23 | Sunstar Inc. | Foods, medical treatments and method relating to effects of promoting the growth of lactobacillus bifidus, preventing allergy and lowering human cholesterol level |
| JP2000143479A (en) * | 1998-11-05 | 2000-05-23 | Kao Corp | Skin-bleaching cosmetic |
| FR2787710B1 (en) * | 1998-12-29 | 2001-02-23 | Clarins | COSMETIC COMPOSITION WITH LIGHTENING EFFECT FOR THE SKIN |
| KR100570120B1 (en) * | 1998-12-30 | 2006-07-27 | 주식회사 코리아나화장품 | Free radical scavenging cosmetics containing hawthorn extract |
| JP2000256175A (en) * | 1999-03-15 | 2000-09-19 | Rasheru Seiyaku Kk | Cosmetic composition |
| JP2000302661A (en) * | 1999-04-21 | 2000-10-31 | Kao Corp | Cosmetic |
| KR20000074101A (en) * | 1999-05-18 | 2000-12-05 | 유상옥 | Cosmetics containing Ramulus mori extracts and Vitamin C for skin whitening |
| KR100327674B1 (en) * | 2000-01-20 | 2002-03-08 | 황분순 | A cosmetic composition of lightening and removing effects in the melanin-like pigmentation |
| KR100724168B1 (en) * | 2001-01-12 | 2007-05-31 | 주식회사 엘지생활건강 | Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation |
| KR100441596B1 (en) * | 2001-06-30 | 2004-07-23 | 주식회사 코스메카코리아 | cosmetic composition containing plant extract complex |
| KR100493845B1 (en) * | 2001-07-04 | 2005-06-08 | 한국화장품주식회사 | Whitening cosmetic composition containing the extract of mountain ginseng adventitious roots |
| FR2847267B1 (en) * | 2002-11-19 | 2006-07-28 | Coletica | METHOD FOR TESTING THE ACTIVITY OF A POTENTIALLY ACTIVE SUBSTANCE FOR INHIBITING THE ENZYMATIC ACTIVITY OF A2 PHOSPHOLIPASE |
| JP2006225359A (en) * | 2005-02-21 | 2006-08-31 | Kanebo Cosmetics Inc | Bleaching cosmetic |
| JP5275779B2 (en) * | 2008-03-19 | 2013-08-28 | 株式会社コーセー | Whitening agent and external preparation for skin |
| US20090317341A1 (en) | 2008-06-18 | 2009-12-24 | Conopco, Inc., D/B/A Unilever | Compositions for Lightening Skin Color |
| JP2011168538A (en) * | 2010-02-18 | 2011-09-01 | Kao Corp | Skin cosmetic |
| KR101220494B1 (en) * | 2010-10-11 | 2013-01-10 | 강원대학교산학협력단 | Cosmetic Composition for Skin Whitening Comprising Liriope Seed Extracts |
| JP5768113B2 (en) * | 2013-11-29 | 2015-08-26 | ポーラ化成工業株式会社 | Method for producing external preparation for skin for pretreatment |
| JP6138317B2 (en) * | 2016-05-10 | 2017-05-31 | 株式会社ノエビア | Topical skin preparation |
| JP7019308B2 (en) * | 2017-05-17 | 2022-02-15 | 花王株式会社 | Emulsifying cosmetics |
| JP7470270B2 (en) * | 2020-01-29 | 2024-04-18 | 株式会社ディーエイチシー | MELANOSOMAL TRANSPORT INHIBITOR AND EXTERNAL SKIN PREPARATION CONTAINING THE TRANSPORT INHIBITOR |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5279032A (en) * | 1975-12-24 | 1977-07-02 | Sunstar Inc | Crude drug compound |
| JPS60104005A (en) * | 1983-11-08 | 1985-06-08 | Kobayashi Kooc:Kk | Skin beutifying cosmetic |
| JPS6267028A (en) * | 1985-09-18 | 1987-03-26 | Shiseido Co Ltd | Skin external preparation |
| JPS6281305A (en) * | 1985-10-01 | 1987-04-14 | Ichimaru Fuarukosu Kk | Skin humectant composed of sugar extracted from bakumondo and skin cosmetic containing same |
| JPS62111908A (en) * | 1985-11-11 | 1987-05-22 | Chubu Seiyaku Kk | Skin agent for external use |
| JPS63115807A (en) * | 1986-11-04 | 1988-05-20 | Eikoudou:Kk | Cosmetic |
| JP2549127B2 (en) * | 1987-09-25 | 1996-10-30 | 三省製薬株式会社 | Topical drug for suppressing melanin production |
| JPH01121205A (en) * | 1987-11-04 | 1989-05-12 | Lion Corp | Skin beautifying cosmetic |
| JP2614474B2 (en) * | 1988-01-20 | 1997-05-28 | サンスター株式会社 | Whitening cosmetics |
| JP2802434B2 (en) * | 1989-03-16 | 1998-09-24 | 一丸ファルコス株式会社 | Lipid peroxide production inhibitor consisting of plant extract |
| JP3056233B2 (en) * | 1989-12-21 | 2000-06-26 | 株式会社資生堂 | Method for producing low-contact sensitizing mugwort extract and cosmetics containing the same |
| JP2903412B2 (en) * | 1989-12-22 | 1999-06-07 | 株式会社コーセー | Cosmetics |
| JP2929304B2 (en) * | 1990-02-13 | 1999-08-03 | 株式会社コーセー | Skin whitening preparation for external use |
| JP3135943B2 (en) * | 1990-10-11 | 2001-02-19 | 株式会社コーセー | Whitening agent |
| JPH05139949A (en) * | 1991-11-12 | 1993-06-08 | Kao Corp | Beautifying cosmetic |
| JP2957334B2 (en) * | 1991-11-26 | 1999-10-04 | ポーラ化成工業株式会社 | Cosmetics |
| JP2711782B2 (en) * | 1991-12-25 | 1998-02-10 | 花王株式会社 | Whitening cosmetics |
| JPH05186324A (en) * | 1991-12-29 | 1993-07-27 | Sunstar Inc | Beautifying cosmetic |
| JPH05201847A (en) * | 1992-01-28 | 1993-08-10 | Sunstar Inc | Skin-beautifying cosmetic |
| JPH05345718A (en) * | 1992-02-03 | 1993-12-27 | Nippon Shinyaku Co Ltd | Whitening cosmetic composition |
| JP3611128B2 (en) * | 1992-03-13 | 2005-01-19 | 株式会社資生堂 | Testosterone-5-α-reductase inhibitor |
| JP3321712B2 (en) * | 1992-06-04 | 2002-09-09 | 株式会社林原生物化学研究所 | Topical hair restorer containing pine extract |
| JPH0624955A (en) * | 1992-07-10 | 1994-02-01 | Kao Corp | Beautifying and whitening cosmetic |
| JPH0672849A (en) * | 1992-07-10 | 1994-03-15 | Kao Corp | Skin color-lightening cosmetic |
| JP3202810B2 (en) * | 1992-10-15 | 2001-08-27 | 協和醗酵工業株式会社 | Cosmetics |
| JPH06145036A (en) * | 1992-11-05 | 1994-05-24 | Tokai Sangyo Kk | Ultraviolet ray-preventing cosmetic composition and its production |
| JP2764510B2 (en) * | 1992-12-28 | 1998-06-11 | 花王株式会社 | Whitening cosmetics |
| JP2787404B2 (en) * | 1993-01-06 | 1998-08-20 | ポーラ化成工業株式会社 | External preparation for skin |
| JP3126543B2 (en) * | 1993-03-03 | 2001-01-22 | 鐘紡株式会社 | Granular cosmetic |
-
1994
- 1994-09-22 JP JP22802694A patent/JP3696271B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0892056A (en) | 1996-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3696271B2 (en) | Whitening cosmetics | |
| JPH08119825A (en) | Hydroxytyrosol, application for skin external medicine or bathing agent | |
| JP2764510B2 (en) | Whitening cosmetics | |
| JP2001163794A (en) | Promoter for production of hyaluronic acid and preparation for external use for skin | |
| JPH08208451A (en) | Skin-beautifying agent mixed with extract of crude medicine from plant | |
| JPH06107531A (en) | Cosmetic for fair skin and beauty | |
| JP2005120023A (en) | Skin care preparation | |
| JP2000143479A (en) | Skin-bleaching cosmetic | |
| JP2711782B2 (en) | Whitening cosmetics | |
| JP3809003B2 (en) | Whitening agent | |
| JP3025605B2 (en) | Whitening cosmetics | |
| JPH05229927A (en) | Skin-whitening cosmetic | |
| JPH0672849A (en) | Skin color-lightening cosmetic | |
| JP6807636B2 (en) | Topical composition | |
| JP3013130B2 (en) | Whitening cosmetics | |
| JP3091040B2 (en) | Skin cosmetics | |
| JP2000096050A (en) | Promoter for production of hyaluronic acid | |
| JPH03200708A (en) | Dermal external agent | |
| JPH0952817A (en) | Beautifying and whitening cosmetic | |
| JP4445658B2 (en) | Cosmetics | |
| JPS6360909A (en) | Skin drug for external use | |
| JPH1149695A (en) | Skin lotion for preventing aging | |
| JP2811479B2 (en) | Hair restoration | |
| JPS6322506A (en) | External preparation for skin | |
| JPH0624955A (en) | Beautifying and whitening cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20031208 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20040120 |
|
| A912 | Removal of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20040227 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050601 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050629 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080708 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090708 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090708 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100708 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110708 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110708 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120708 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120708 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130708 Year of fee payment: 8 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |